Literature DB >> 1777367

Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children.

S M Mansor1, M E Molyneux, T E Taylor, S A Ward, J J Wirima, G Edwards.   

Abstract

1. We have measured plasma concentrations of alpha 1-acid glycoprotein (AGP) in 18 healthy children and 85 children with falciparum malaria in Malawi. In addition, we determined the degree of protein binding of quinine (QN) in the plasma of 52 of the patients and each of the healthy controls. 2. The mean plasma AGP concentration was higher in patients than in controls (P less than 0.0001) and remained elevated 3 weeks after complete resolution of malaria infection. 3. The mean unbound QN fraction was significantly less (P less than 0.00001) in patients with malaria (0.128 +/- 0.037) than in controls (0.193 +/- 0.051) and significantly higher (P = 0.02) in convalescence (0.153 +/- 0.067) than during acute illness. 4. There were highly significant negative correlations between plasma AGP concentration and the free QN fraction in spiked plasma samples (r = -0.534, P less than 0.0001, n = 93) and in clinical samples (r = -0.484, P less than 0.00001, n = 225). There was a significant positive correlation between plasma concentrations of AGP and another acute phase reactant, C reactive protein (P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777367      PMCID: PMC1368524          DOI: 10.1111/j.1365-2125.1991.tb03905.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria.

Authors:  S M Mansor; T E Taylor; C S McGrath; G Edwards; S A Ward; J J Wirima; M E Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jul-Aug       Impact factor: 2.184

2.  Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron.

Authors:  R Bertini; M Bianchi; A Erroi; P Villa; P Ghezzi
Journal:  J Leukoc Biol       Date:  1989-09       Impact factor: 4.962

3.  Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon.

Authors:  R Bertini; M Bianchi; P Villa; P Ghezzi
Journal:  Int J Immunopharmacol       Date:  1988

4.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

5.  High-performance liquid chromatographic analysis of quinine and its diastereoisomer quinidine.

Authors:  G W Mihaly; K M Hyman; R A Smallwood; K J Hardy
Journal:  J Chromatogr       Date:  1987-03-20

6.  Binding of quinine to plasma proteins in falciparum malaria.

Authors:  K Silamut; N J White; S Looareesuwan; D A Warrell
Journal:  Am J Trop Med Hyg       Date:  1985-07       Impact factor: 2.345

7.  Differences in the binding of quinine and quinidine to plasma proteins.

Authors:  G W Mihaly; M S Ching; M B Klejn; J Paull; R A Smallwood
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

8.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

9.  Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; M J Warrell; D Bunnag; T Harinasuta
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

10.  Tumor necrosis factor and disease severity in children with falciparum malaria.

Authors:  G E Grau; T E Taylor; M E Molyneux; J J Wirima; P Vassalli; M Hommel; P H Lambert
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

View more
  19 in total

Review 1.  Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria.

Authors:  P A Winstanley; W M Watkins
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 2.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

3.  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.

Authors:  Edward T Morgan; Joseph L Dempsey; Sylvie M Mimche; Tracey J Lamb; Supriya Kulkarni; Julia Yue Cui; Hyunyoung Jeong; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

4.  Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.

Authors:  Robert H Barker; Sameer Urgaonkar; Ralph Mazitschek; Cassandra Celatka; Renato Skerlj; Joseph F Cortese; Erin Tyndall; Hanlan Liu; Mandy Cromwell; Amar Bir Sidhu; Jose E Guerrero-Bravo; Keila N Crespo-Llado; Adelfa E Serrano; Jing-Wen Lin; Chris J Janse; Shahid M Khan; Manoj Duraisingh; Bradley I Coleman; Inigo Angulo-Barturen; María Belén Jiménez-Díaz; Noemí Magán; Vanesa Gomez; Santiago Ferrer; María Santos Martínez; Sergio Wittlin; Petros Papastogiannidis; Thomas O'Shea; Jeffrey D Klinger; Mark Bree; Edward Lee; Mikaela Levine; Roger C Wiegand; Benito Munoz; Dyann F Wirth; Jon Clardy; Ian Bathurst; Edmund Sybertz
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

6.  In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera.

Authors:  P Ringwald; F S Meche; J Bickii; L K Basco
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Quinine distribution in mice with Plasmodium berghei malaria.

Authors:  Eric Pussard; Alexandra Bernier; Elyane Fouquet; Patrice Bouree
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

Review 8.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.

Authors:  J R Dyer; T M Davis; C Giele; T Annus; P Garcia-Webb; J Robson
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

10.  Interactions among primaquine, malaria infection and other antimalarials in Thai subjects.

Authors:  G Edwards; C S McGrath; S A Ward; W Supanaranond; S Pukrittayakamee; T M Davis; N J White
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.